ZEPPOLA, TEA
ZEPPOLA, TEA
Facoltà Dipartimentale di Medicina e Chirurgia
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
2019-01-01 Cortellini, A; Bersanelli, M; Buti, S; Cannita, K; Santini, D; Perrone, F; Giusti, R; Tiseo, M; Michiara, M; Di Marino, P; Tinari, N; De Tursi, M; Zoratto, F; Veltri, E; Marconcini, R; Malorgio, F; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Botticelli, A; Cappellini, Gca; De Galitiis, F; Vitale, Mg; Rastelli, F; Pergolesi, F; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Chiari, R; Ricciuti, B; De Giglio, A; Iacono, D; Gelibter, A; Occhipinti, Ma; Parisi, A; Porzio, G; Fargnoli, Mc; Ascierto, Pa; Ficorella, C; Natoli, C
ADDIO-BTcP " Evaluation of an UCBM Algorithm-Driven calculator of initial rapid-onset opioids Dose in Italian Oncological patients suffering from breakthrough cancer pain (BTcP): a randomized, multicentric, prospective, phase II trial”
2024-06-06 Zeppola, Tea
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma
2014-01-01 Guida, Fm; Santoni, M; Conti, A; Burattini, L; Savini, A; Zeppola, T; Caricato, M; Cascinu, S; Tonini, G; Santini, D.
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events
2020-01-01 Cortellini, A; Bersanelli, M; Santini, D; Buti, S; Tiseo, M; Cannita, K; Perrone, F; Giusti, R; De Tursi, M; Zoratto, F; Marconcini, R; Russano, M; Zeppola, T; Anesi, C; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; De Galitiis, F; Vitale, Mg; Rastelli, F; Tudini, M; Silva, Rr; Atzori, F; Chiari, R; Ricciuti, B; De Giglio, A; Migliorino, Mr; Mallardo, D; Vanella, V; Mosillo, C; Bracarda, S; Rinaldi, S; Berardi, R; Natoli, C; Ficorella, C; Porzio, G; Ascierto, Pa
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
2020-01-01 Dell'Aquila, E; Zeppola, T; Stellato, M; Pantano, F; Scartozzi, M; Madaudo, C; Pietrantonio, F; Cremolini, C; Aprile, G; Vincenzi, B; Moretto, R; Puzzoni, M; Garattini, Sk; Lobefaro, R; Tonini, G; Santini, D
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study
2020-01-01 Pantano, F; Manca, P; Armento, G; Zeppola, T; Onorato, A; Iuliani, M; Simonetti, S; Vincenzi, B; Santini, D; Mercadante, S; Marchetti, P; Cuomo, A; Caraceni, A; Mediati, Rd; Vellucci, R; Mammucari, M; Natoli, S; Lazzari, M; Dauri, M; Adile, C; Airoldi, M; Azzarello, G; Blasi, L; Chiurazzi, B; Degiovanni, D; Fusco, F; Guardamagna, V; Liguori, S; Palermo, L; Mameli, S; Masedu, F; Mazzei, T; Melotti, Rm; Menardo, V; Miotti, D; Moroso, S; Pascoletti, G; De Santis, S; Orsetti, R; Papa, A; Ricci, S; Scelzi, E; Sofia, M; Aielli, F; Valle, A; Tonini, G
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study
2019-01-01 Cortellini, A; Buti, S; Santini, D; Perrone, F; Giusti, R; Tiseo, M; Bersanelli, M; Michiara, M; Grassadonia, A; Brocco, D; Tinari, N; De Tursi, M; Zoratto, F; Veltri, E; Marconcini, R; Malorgio, F; Garufi, C; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Botticelli, A; Antonini Cappellini, Gc; De Galitiis, F; Vitale, Mg; Sabbatini, R; Bracarda, S; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Chiari, R; Ricciuti, B; Iacono, D; Migliorino, Mr; Rossi, A; Porzio, G; Cannita, K; Ciciarelli, V; Fargnoli, Mc; Ascierto, Pa; Ficorella, C
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients
2019-01-01 Cortellini, A; Chiari, R; Ricciuti, B; Metro, G; Perrone, F; Tiseo, M; Bersanelli, M; Bordi, P; Santini, D; Giusti, R; Grassadonia, A; Di Marino, P; Tinari, N; De Tursi, M; Zoratto, F; Veltri, E; Malorgio, F; Garufi, C; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Iacono, D; Migliorino, Mr; Porzio, G; Cannita, K; Ficorella, C; Buti, S
Denosumab for cancer-related bone loss
2020-01-01 Dell'Aquila, E; Armento, G; Iuliani, M; Simonetti, S; D'Onofrio, L; Zeppola, T; Madaudo, C; Russano, M; Citarella, F; Ribelli, G; Pantano, F; Vincenzi, B; Tonini, G; Santini, D
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice
2019-01-01 Cortellini, A; Vitale, Mg; De Galitiis, F; Di Pietro, Fr; Berardi, R; Torniai, M; De Tursi, M; Grassadonia, A; Di Marino, P; Santini, D; Zeppola, T; Anesi, C; Gelibter, A; Occhipinti, Ma; Botticelli, A; Marchetti, P; Rastelli, F; Pergolesi, F; Tudini, M; Silva, Rr; Mallardo, D; Vanella, V; Ficorella, C; Porzio, G; Ascierto, Pa
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study
2020-01-01 Cortellini, A; Buti, S; Bersanelli, M; Giusti, R; Perrone, F; Di Marino, P; Tinari, N; De Tursi, M; Grassadonia, A; Cannita, K; Tessitore, A; Zoratto, F; Veltri, E; Malorgio, F; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Botticelli, A; Cappellini, Gca; De Galitiis, F; Vitale, Mg; Rastelli, F; Pergolesi, F; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Iacono, D; Migliorino, Mr; Gelibter, A; Occhipinti, Ma; Martella, F; Inno, A; Gori, S; Bracarda, S; Zannori, C; Mosillo, C; Parisi, A; Porzio, G; Mallardo, D; Fargnoli, Mc; Tiseo, M; Santini, D; Ascierto, Pa; Ficorella, C
Movement-Based Interventions in Patients Affected by Bone Metastases: Impact on Physical Function and Functional Autonomy—A Systematic Review
2025-01-01 Petrucci, Giorgia; Broccolo, Agnese; Marchetti, Anna; Monterosso, Chiara; Casale, Giuseppe; Timarco, Chiara; Zeppola, Tea; Dsoke, Silvia; Sandri, Elena; Piredda, Michela; Papalia, Giuseppe Francesco; De Marinis, Maria Grazia
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort
2021-01-01 Santini, D.; Zeppola, T.; Russano, M.; Citarella, F.; Anesi, C.; Buti, S.; Tucci, M.; Russo, A.; Sergi, M. C.; Adamo, V.; Stucci, L. S.; Bersanelli, M.; Mazzaschi, G.; Spagnolo, F.; Rastelli, F.; Giorgi, F. C.; Giusti, R.; Filetti, M.; Marchetti, P.; Botticelli, A.; Gelibter, A.; Siringo, M.; Ferrari, M.; Marconcini, R.; Vitale, M. G.; Nicolardi, L.; Chiari, R.; Ghidini, M.; Nigro, O.; Grossi, F.; De Tursi, M.; Di Marino, P.; Pala, L.; Queirolo, P.; Bracarda, S.; Macrini, S.; Gori, S.; Inno, A.; Zoratto, F.; Tanda, E. T.; Mallardo, D.; Vitale, M. G.; Talbot, T.; Ascierto, P. A.; Pinato, D. J.; Ficorella, C.; Porzio, G.; Cortellini, A.
Prognostic and predictive factors in pancreatic cancer
2020-01-01 Dell'Aquila, E.; Fulgenzi, C. A. M.; Minelli, A.; Citarella, F.; Stellato, M.; Pantano, F.; Russano, M.; Cursano, M. C.; Napolitano, A.; Zeppola, T.; Vincenzi, B.; Tonini, G.; Santini, D.
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
2018-01-01 Dell'Aquila, E; Cremolini, C; Zeppola, T; Lonardi, S; Bergamo, F; Masi, G; Stellato, M; Mamorino, F; Schirripa, M; Urbano, F; Ronzoni, M; Tomasello, G; Zaniboni, A; Racca, P; Buonadonna, A; Allegrini, G; Fea, E; Di Donato, S; Chiara, S; Tonini, G; Tomcikova, D; Boni, L; Falcone, A; Santini, D
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?
2017-01-01 Aprile, G; Negri, Fv; Giuliani, F; De Carlo, E; Melisi, D; Simionato, F; Silvestris, N; Brunetti, O; Leone, F; Marino, D; Santini, D; Dell'Aquila, E; Zeppola, T; Puzzoni, M; Scartozzi, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable | 1-gen-2019 | Cortellini, A; Bersanelli, M; Buti, S; Cannita, K; Santini, D; Perrone, F; Giusti, R; Tiseo, M; Michiara, M; Di Marino, P; Tinari, N; De Tursi, M; Zoratto, F; Veltri, E; Marconcini, R; Malorgio, F; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Botticelli, A; Cappellini, Gca; De Galitiis, F; Vitale, Mg; Rastelli, F; Pergolesi, F; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Chiari, R; Ricciuti, B; De Giglio, A; Iacono, D; Gelibter, A; Occhipinti, Ma; Parisi, A; Porzio, G; Fargnoli, Mc; Ascierto, Pa; Ficorella, C; Natoli, C | |
| ADDIO-BTcP " Evaluation of an UCBM Algorithm-Driven calculator of initial rapid-onset opioids Dose in Italian Oncological patients suffering from breakthrough cancer pain (BTcP): a randomized, multicentric, prospective, phase II trial” | 6-giu-2024 | Zeppola, Tea | |
| Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma | 1-gen-2014 | Guida, Fm; Santoni, M; Conti, A; Burattini, L; Savini, A; Zeppola, T; Caricato, M; Cascinu, S; Tonini, G; Santini, D. | |
| Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events | 1-gen-2020 | Cortellini, A; Bersanelli, M; Santini, D; Buti, S; Tiseo, M; Cannita, K; Perrone, F; Giusti, R; De Tursi, M; Zoratto, F; Marconcini, R; Russano, M; Zeppola, T; Anesi, C; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; De Galitiis, F; Vitale, Mg; Rastelli, F; Tudini, M; Silva, Rr; Atzori, F; Chiari, R; Ricciuti, B; De Giglio, A; Migliorino, Mr; Mallardo, D; Vanella, V; Mosillo, C; Bracarda, S; Rinaldi, S; Berardi, R; Natoli, C; Ficorella, C; Porzio, G; Ascierto, Pa | |
| Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? | 1-gen-2020 | Dell'Aquila, E; Zeppola, T; Stellato, M; Pantano, F; Scartozzi, M; Madaudo, C; Pietrantonio, F; Cremolini, C; Aprile, G; Vincenzi, B; Moretto, R; Puzzoni, M; Garattini, Sk; Lobefaro, R; Tonini, G; Santini, D | |
| Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study | 1-gen-2020 | Pantano, F; Manca, P; Armento, G; Zeppola, T; Onorato, A; Iuliani, M; Simonetti, S; Vincenzi, B; Santini, D; Mercadante, S; Marchetti, P; Cuomo, A; Caraceni, A; Mediati, Rd; Vellucci, R; Mammucari, M; Natoli, S; Lazzari, M; Dauri, M; Adile, C; Airoldi, M; Azzarello, G; Blasi, L; Chiurazzi, B; Degiovanni, D; Fusco, F; Guardamagna, V; Liguori, S; Palermo, L; Mameli, S; Masedu, F; Mazzei, T; Melotti, Rm; Menardo, V; Miotti, D; Moroso, S; Pascoletti, G; De Santis, S; Orsetti, R; Papa, A; Ricci, S; Scelzi, E; Sofia, M; Aielli, F; Valle, A; Tonini, G | |
| Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study | 1-gen-2019 | Cortellini, A; Buti, S; Santini, D; Perrone, F; Giusti, R; Tiseo, M; Bersanelli, M; Michiara, M; Grassadonia, A; Brocco, D; Tinari, N; De Tursi, M; Zoratto, F; Veltri, E; Marconcini, R; Malorgio, F; Garufi, C; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Botticelli, A; Antonini Cappellini, Gc; De Galitiis, F; Vitale, Mg; Sabbatini, R; Bracarda, S; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Chiari, R; Ricciuti, B; Iacono, D; Migliorino, Mr; Rossi, A; Porzio, G; Cannita, K; Ciciarelli, V; Fargnoli, Mc; Ascierto, Pa; Ficorella, C | |
| Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients | 1-gen-2019 | Cortellini, A; Chiari, R; Ricciuti, B; Metro, G; Perrone, F; Tiseo, M; Bersanelli, M; Bordi, P; Santini, D; Giusti, R; Grassadonia, A; Di Marino, P; Tinari, N; De Tursi, M; Zoratto, F; Veltri, E; Malorgio, F; Garufi, C; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Iacono, D; Migliorino, Mr; Porzio, G; Cannita, K; Ficorella, C; Buti, S | |
| Denosumab for cancer-related bone loss | 1-gen-2020 | Dell'Aquila, E; Armento, G; Iuliani, M; Simonetti, S; D'Onofrio, L; Zeppola, T; Madaudo, C; Russano, M; Citarella, F; Ribelli, G; Pantano, F; Vincenzi, B; Tonini, G; Santini, D | |
| Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice | 1-gen-2019 | Cortellini, A; Vitale, Mg; De Galitiis, F; Di Pietro, Fr; Berardi, R; Torniai, M; De Tursi, M; Grassadonia, A; Di Marino, P; Santini, D; Zeppola, T; Anesi, C; Gelibter, A; Occhipinti, Ma; Botticelli, A; Marchetti, P; Rastelli, F; Pergolesi, F; Tudini, M; Silva, Rr; Mallardo, D; Vanella, V; Ficorella, C; Porzio, G; Ascierto, Pa | |
| Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study | 1-gen-2020 | Cortellini, A; Buti, S; Bersanelli, M; Giusti, R; Perrone, F; Di Marino, P; Tinari, N; De Tursi, M; Grassadonia, A; Cannita, K; Tessitore, A; Zoratto, F; Veltri, E; Malorgio, F; Russano, M; Anesi, C; Zeppola, T; Filetti, M; Marchetti, P; Botticelli, A; Cappellini, Gca; De Galitiis, F; Vitale, Mg; Rastelli, F; Pergolesi, F; Berardi, R; Rinaldi, S; Tudini, M; Silva, Rr; Pireddu, A; Atzori, F; Iacono, D; Migliorino, Mr; Gelibter, A; Occhipinti, Ma; Martella, F; Inno, A; Gori, S; Bracarda, S; Zannori, C; Mosillo, C; Parisi, A; Porzio, G; Mallardo, D; Fargnoli, Mc; Tiseo, M; Santini, D; Ascierto, Pa; Ficorella, C | |
| Movement-Based Interventions in Patients Affected by Bone Metastases: Impact on Physical Function and Functional Autonomy—A Systematic Review | 1-gen-2025 | Petrucci, Giorgia; Broccolo, Agnese; Marchetti, Anna; Monterosso, Chiara; Casale, Giuseppe; Timarco, Chiara; Zeppola, Tea; Dsoke, Silvia; Sandri, Elena; Piredda, Michela; Papalia, Giuseppe Francesco; De Marinis, Maria Grazia | |
| PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort | 1-gen-2021 | Santini, D.; Zeppola, T.; Russano, M.; Citarella, F.; Anesi, C.; Buti, S.; Tucci, M.; Russo, A.; Sergi, M. C.; Adamo, V.; Stucci, L. S.; Bersanelli, M.; Mazzaschi, G.; Spagnolo, F.; Rastelli, F.; Giorgi, F. C.; Giusti, R.; Filetti, M.; Marchetti, P.; Botticelli, A.; Gelibter, A.; Siringo, M.; Ferrari, M.; Marconcini, R.; Vitale, M. G.; Nicolardi, L.; Chiari, R.; Ghidini, M.; Nigro, O.; Grossi, F.; De Tursi, M.; Di Marino, P.; Pala, L.; Queirolo, P.; Bracarda, S.; Macrini, S.; Gori, S.; Inno, A.; Zoratto, F.; Tanda, E. T.; Mallardo, D.; Vitale, M. G.; Talbot, T.; Ascierto, P. A.; Pinato, D. J.; Ficorella, C.; Porzio, G.; Cortellini, A. | |
| Prognostic and predictive factors in pancreatic cancer | 1-gen-2020 | Dell'Aquila, E.; Fulgenzi, C. A. M.; Minelli, A.; Citarella, F.; Stellato, M.; Pantano, F.; Russano, M.; Cursano, M. C.; Napolitano, A.; Zeppola, T.; Vincenzi, B.; Tonini, G.; Santini, D. | |
| Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO | 1-gen-2018 | Dell'Aquila, E; Cremolini, C; Zeppola, T; Lonardi, S; Bergamo, F; Masi, G; Stellato, M; Mamorino, F; Schirripa, M; Urbano, F; Ronzoni, M; Tomasello, G; Zaniboni, A; Racca, P; Buonadonna, A; Allegrini, G; Fea, E; Di Donato, S; Chiara, S; Tonini, G; Tomcikova, D; Boni, L; Falcone, A; Santini, D | |
| Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? | 1-gen-2017 | Aprile, G; Negri, Fv; Giuliani, F; De Carlo, E; Melisi, D; Simionato, F; Silvestris, N; Brunetti, O; Leone, F; Marino, D; Santini, D; Dell'Aquila, E; Zeppola, T; Puzzoni, M; Scartozzi, M |